Literature DB >> 10440715

Mu-opioid and NMDA-type glutamate receptors are often colocalized in spiny neurons within patches of the caudate-putamen nucleus.

H Wang1, K N Gracy, V M Pickel.   

Abstract

The patch compartments of the caudate-putamen nucleus (CPN) are enriched in mu-opioid receptors (MORs) and have been recently implicated in reward-related behaviors. This function has been established more clearly in the nucleus accumbens, where physiological and anatomical studies show reward-associated interactions involving MORs and N-methyl-D-aspartate-type glutamate receptors (NMDARs). We examined the immunolabeling for MOR and NMDAR subunit NR1 in patches of the rat CPN to determine the potential relevance of dual activation of the respective receptors. Electron microscopy showed the presence of MOR and/or NR1 immunoreactivity (IR) in many perikarya, dendrites, and spines and in morphologically heterogeneous axon terminals. In each 1,000-microm(2) area, the dually labeled dendrites and spines constituted 65% (37/57) and 37% (9/25) of the total NR1-labeled and 34% (37/109) and 13% (9/71) of the total MOR-labeled dendritic profiles. Dually labeled spines received asymmetric excitatory-type synapses from terminals, which were generally unlabeled, but also occasionally contained MOR and/or NR1. The asymmetric synapses comprised the majority (81%) of the total 263 synaptic contacts between MOR- and NR1-labeled neuronal profiles. In dendrites and spines, MOR-IR was localized mainly along nonsynaptic plasma membranes, whereas NR1-IR was more often associated with asymmetric postsynaptic densities and cytoplasmic organelles. In contrast to dendrites, 6% (1.3/22) of NR1-IR and 4% (1.3/33) of MOR-IR axon terminals were dually labeled in each 1,000-microm(2) area. Most singly or dually labeled terminals formed asymmetric synapses with MOR- or NR1-labeled spines. Our results suggest that opioids acting through MOR and excitatory neurotransmitters through NMDAR dually regulate the output of single spiny neurons and some of their excitatory afferents in the CPN. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440715     DOI: 10.1002/(sici)1096-9861(19990913)412:1<132::aid-cne10>3.0.co;2-b

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  19 in total

1.  Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

Authors:  J J Rodriguez; K Mackie; V M Pickel
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

2.  Glutaminergic signaling in the caudate nucleus is required for behavioral sensitization to methylphenidate.

Authors:  Nicholas King; Samuel Floren; Natasha Kharas; Ming Thomas; Nachum Dafny
Journal:  Pharmacol Biochem Behav       Date:  2019-06-19       Impact factor: 3.533

3.  Preferential relocation of the N-methyl-D-aspartate receptor NR1 subunit in nucleus accumbens neurons that contain dopamine D1 receptors in rats showing an apomorphine-induced sensorimotor gating deficit.

Authors:  Y Hara; V M Pickel
Journal:  Neuroscience       Date:  2008-04-12       Impact factor: 3.590

Review 4.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

5.  Ultrastructural relationship between the mu opioid receptor and its interacting protein, GPR177, in striatal neurons.

Authors:  Arith-Ruth S Reyes; Robert Levenson; Wade Berrettini; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2010-09-21       Impact factor: 3.252

6.  Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors.

Authors:  H Wang; V M Pickel
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

7.  Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro.

Authors:  J A Gurwell; A Nath; Q Sun; J Zhang; K M Martin; Y Chen; K F Hauser
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

8.  Unraveling glutamate-opioid receptor interactions using high-resolution electron microscopy: implications for addiction-related processes.

Authors:  Jillian L Scavone; Esther Asan; Elisabeth J Van Bockstaele
Journal:  Exp Neurol       Date:  2011-04-01       Impact factor: 5.330

9.  Ultrastructural relationship between N-methyl-D-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala.

Authors:  M J Glass; L Vanyo; L Quimson; V M Pickel
Journal:  Neuroscience       Date:  2009-07-14       Impact factor: 3.590

10.  Immunohistochemical distribution and subcellular localization of the somatostatin receptor subtype 1 (sst1) in the rat hypothalamus.

Authors:  Thomas Stroh; Philippe Sarret; Gloria S Tannenbaum; Alain Beaudet
Journal:  Neurochem Res       Date:  2006-03-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.